Effects of abiraterone acetate plus prednisone on bone turnover markers in chemotherapy-naïve mCRPC patients after ADT failure: a prospective analysis of the italian real-world study ABITUDE
Publication date: Available online 2 December 2020Source: Journal of Bone OncologyAuthor(s): Daniele Santini, Saverio Cinieri, Donatello Gasparro, Roberto Bordonaro, Pamela Francesca Guglielmini, Vincenzo Emanuele Chiuri, Rolando M D'Angelillo, Giovanni Luca Ceresoli, Daniele Fagnani, Mirko Acquati, Manlio Mencoboni, Gaetano Lanzetta, Donata Sartori, Paolo Carlini, Fabiana Panebianco, Patrizia Beccaglia, Giuseppe Procopio
Source: Journal of Bone Oncology - Category: Cancer & Oncology Source Type: research
More News: Abiraterone Acetate | Cancer & Oncology | Chemotherapy | Italy Health | Men | Prednisone | Study